CID 135980528

Itk inhibitor 2

Structural Information

Molecular Formula
C25H33N5O2
SMILES
C[C@@H](C(=O)N(C)C1=CC2=C(C=C1)C=C(N2)C3=NNC4=C3CCC(C4)(C)C)N5CCOCC5
InChI
InChI=1S/C25H33N5O2/c1-16(30-9-11-32-12-10-30)24(31)29(4)18-6-5-17-13-21(26-20(17)14-18)23-19-7-8-25(2,3)15-22(19)27-28-23/h5-6,13-14,16,26H,7-12,15H2,1-4H3,(H,27,28)/t16-/m0/s1
InChIKey
ZZZXGCPVQQOASC-INIZCTEOSA-N
Compound name
(2S)-N-[2-(6,6-dimethyl-1,4,5,7-tetrahydroindazol-3-yl)-1H-indol-6-yl]-N-methyl-2-morpholin-4-ylpropanamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

56
Patents

435.26343 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 436.270706 206.0
[M+Na]+ 458.252648 209.8
[M-H]- 434.256154 211.3
[M+NH4]+ 453.297253 214.6
[M+K]+ 474.226588 205.1
[M+H-H2O]+ 418.260690 195.4
[M+HCOO]- 480.261631 214.1
[M+CH3COO]- 494.277281 212.0
[M+Na-2H]- 456.238096 202.0
[M]+ 435.26288142 202.2
[M]- 435.26397858 202.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe